Disclaimer: Note that the firm is no longer accepting cases for the anti-psychotic medication Abilify or Tylenol autism cases. Thank you.
Select Page

Fosamax Label Change to Add Warning for Femur Fractures

This has been a long time coming! I have been actively involved in Fosamax litigation since 2006 and have lectured at numerous seminars on the subject. Back then, it was just osteonecrosis of the jaw (ONJ) on the radar. But soon after, a deeper, more ominous danger...
Hundreds of Fosamax Fracture Cases Reinstated

Hundreds of Fosamax Fracture Cases Reinstated

This week the Third Circuit Court of Appeals decided to reverse a ruling by U.S. District court Joel Pisano. Judge Pisano dismissed all federal court Fosamax cases on federal preemption grounds. The Third Court decided that whether the FDA would have rejected a...

New Jersey Fosamax Femur Fracture Trials on the Horizon

This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. Things are certainly heating up in the pursuit of justice for the thousands of victims of Fosamax femur fracture injuries. I am excited to announce that the first Fosamax femur fracture...

FDA Considers 5 Year Limit on Fosamax Use

This is a long time coming. It is about time that the FDA is finally coming around to the notion that long-term use of bisphosphonates like Fosamax is just a bad idea. The simple fact is that the longer a person uses Fosamax, the greater the likelihood that he/she...

Consumer Alert! Fosamax Linked to Esphogeal Cancer

This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. Another serious safety concern with Fosamax! Can this drug get any worse in terms of a safety profile? Today FDA Communications issued a warning derived from a study from the UK General...
×
What Our Clients Are Saying